AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jasper Therapeutics, Inc. Director's Dealing 2021

Oct 4, 2021

34406_dirs_2021-10-04_072c410c-75e8-42f4-930f-8bb566b5dfb6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jasper Therapeutics, Inc. (JSPR)
CIK: 0001788028
Period of Report: 2021-09-24

Reporting Person: ROCHE HOLDING LTD (10% Owner)
Reporting Person: ROCHE FINANCE LTD (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Voting Common Stock	4624606	Direct

Footnotes

F1: Roche Finance Ltd ("Roche Finance") is the direct beneficial owner of these securities of the Issuer. Roche Finance is a wholly-owned subsidiary of Roche Holding Ltd, a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding Ltd is the indirect beneficial owner of these securities of the Issuer.